These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 32323822)
1. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells. Fan Z; Zheng W; Li H; Wu W; Liu X; Sun Z; Hu H; Du L; Jia Q; Liu Q Oncol Rep; 2020 May; 43(5):1641-1649. PubMed ID: 32323822 [TBL] [Abstract][Full Text] [Related]
2. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
3. Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma. Liu GM; Li Q; Zhang PF; Shen SL; Xie WX; Chen B; Wu J; Hu WJ; Huang XY; Peng BG Cell Death Dis; 2018 Nov; 9(11):1132. PubMed ID: 30429463 [TBL] [Abstract][Full Text] [Related]
4. Yang YL; Tsai MC; Chang YH; Wang CC; Chu PY; Lin HY; Huang YH Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206143 [TBL] [Abstract][Full Text] [Related]
5. Significance of Lysyl oxidase‑like 2 gene expression on the epithelial‑mesenchymal status of hepatocellular carcinoma. Ninomiya G; Yamada S; Hayashi M; Takeda S; Suenaga M; Takami H; Kanda M; Iwata N; Niwa Y; Tanaka C; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Oncol Rep; 2018 Jun; 39(6):2664-2672. PubMed ID: 29620290 [TBL] [Abstract][Full Text] [Related]
6. GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells. Li SS; Chen DM; Chen LB; Wei H; Wang JL; Xiao J; Huang YH; Lian YF Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880590 [TBL] [Abstract][Full Text] [Related]
7. Multiple Roles of LOXL2 in the Progression of Hepatocellular Carcinoma and Its Potential for Therapeutic Targeting. Radić J; Kožik B; Nikolić I; Kolarov-Bjelobrk I; Vasiljević T; Vranjković B; Despotović S Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511503 [TBL] [Abstract][Full Text] [Related]
8. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α. Kim SM; Han JM; Le TT; Sohng JK; Jung HJ Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967 [TBL] [Abstract][Full Text] [Related]
9. FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1α. Shi L; He C; Li Z; Wang Z; Zhang Q Neoplasma; 2017; 64(4):535-542. PubMed ID: 28485159 [TBL] [Abstract][Full Text] [Related]
10. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. Wu S; Zheng Q; Xing X; Dong Y; Wang Y; You Y; Chen R; Hu C; Chen J; Gao D; Zhao Y; Wang Z; Xue T; Ren Z; Cui J J Exp Clin Cancer Res; 2018 May; 37(1):99. PubMed ID: 29728125 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma. Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980 [TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863 [TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396 [TBL] [Abstract][Full Text] [Related]
14. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma. Shao B; Zhao X; Liu T; Zhang Y; Sun R; Dong X; Liu F; Zhao N; Zhang D; Wu L; Wang Y; Wang M; Meng J; Lin X; Sun B J Cell Mol Med; 2019 Feb; 23(2):1363-1374. PubMed ID: 30506621 [TBL] [Abstract][Full Text] [Related]
15. RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signaling. Zhou YJ; Yang ML; He X; Gu HY; Ren JH; Cheng ST; Fu Z; Zhang ZZ; Chen J J Exp Clin Cancer Res; 2024 Feb; 43(1):45. PubMed ID: 38326908 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression. Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983 [TBL] [Abstract][Full Text] [Related]
17. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
18. MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect. Chen Z; Zuo X; Zhang Y; Han G; Zhang L; Wu J; Wang X Cell Death Dis; 2018 May; 9(5):549. PubMed ID: 29748591 [TBL] [Abstract][Full Text] [Related]
19. Dual action of a selective cyclooxygenase-2 inhibitor on vascular endothelial growth factor expression in human hepatocellular carcinoma cells: novel involvement of discoidin domain receptor 2. Lee NO; Park JW; Lee JA; Shim JH; Kong SY; Kim KT; Lee YS J Cancer Res Clin Oncol; 2012 Jan; 138(1):73-84. PubMed ID: 22009181 [TBL] [Abstract][Full Text] [Related]
20. Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2. Chen X; Kou Y; Lu Y; Pu Y J Cell Biochem; 2020 Jan; 121(1):165-173. PubMed ID: 31162697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]